<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62118">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01966536</url>
  </required_header>
  <id_info>
    <org_study_id>Neofol2013</org_study_id>
    <nct_id>NCT01966536</nct_id>
  </id_info>
  <brief_title>CD133 Transplantation to Generate Oocytes in Poor Ovarian Reserve</brief_title>
  <official_title>CD133+ Autologue Transplantation to Promote Ovarian Follicles Development in Women With Poor Ovarian Reserve.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario La Fe</source>
  <oversight_info>
    <authority>Spain: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women delay maternity and, as a consequence, available oocyte number and their quality
      decrease (9-18% of all IVF patients). Different treatment protocols have been developped
      nevertheless none of them optimal: the number of oocytes retrieved depends on the present
      ones. New generation of oocytes and follicles has been defended by some authors and bone
      marrow seems to be involved. What seems crucial is the niche that produces paracrine signals
      able to activate dormant cells and to attract undifferentiated cells from other tissues
      (homing). This phenomenon has been described by our group in other human reproductive
      tissues like endometrium. The purpose of the study is to improve ovarian reserve in
      unfertile women with poor ovarian reserve by means of bone marrow protective capacity.

      CD133+ cells obtained from bone marrow will be delivered into the ovarian artery allowing
      them to colonize ovarian niche.

      The study hypothesis is that CD133+ cells will improve ovarian reserve differentiating
      themselves into germ cells or, more likely, stimulating the niche to activate dormant
      follicles.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Ovarian reserve</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Measured by FSH-LH, oestradiol, AMH, antral follicle count</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ovarian response to stimulation for oocyte retrieval</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of MII oocytes obtained</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ovarian Reserve</condition>
  <arm_group>
    <arm_group_label>Poor ovarian reserve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Autologous transplantation of CD133+ cells into ovarian artery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CD133+ cells transplantation into ovarian artery of one ovary</intervention_name>
    <arm_group_label>Poor ovarian reserve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt; or= 40 years old

          -  FSH&lt;15UI/L

          -  poor ovarian response after controlled ovarian stimulation with conventional doses
             (&lt;3 oocytes) or two episodes of poor ovarian response after ovarian stimulation with
             maximal doses even if young or normal ovarian reserve study.

          -  Antral follicle count&gt;2

          -  &gt;1 antral follicle in the perfunded ovary

          -  AMH between 0,5 and 1pmol/L

          -  regular menstrual bleeding each 21-35 days

          -  To be candidate to autologous hematopoietic progenitors transplantation

        Exclusion Criteria:

          -  Ovarian endometriosis

          -  Anovulation

          -  Any ovarian surgery considered risk factor of low ovarian response.

          -  Genetic factors associated to low ovarian response (Turner syndrome, FMR1
             mutations...)

          -  Adquired conditions determining low response (chemotherapy, radiotherapy...)

          -  BMI &gt; or = 30kg/m2

          -  Allergie to iodine

          -  Kidney failure
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Pellicer, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Fe</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susana Martínez, Doctor</last_name>
    <phone>961244000</phone>
    <phone_ext>244116</phone_ext>
    <email>susamc12@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mónica Romeu, Doctor</last_name>
    <phone>961244000</phone>
    <phone_ext>244116</phone_ext>
    <email>monicaromeu@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susana Martínez, Doctor</last_name>
      <phone>961244000</phone>
      <phone_ext>244116</phone_ext>
      <email>susamc12@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Mónica Romeu, Doctor</last_name>
      <phone>961244000</phone>
      <phone_ext>244116</phone_ext>
      <email>monicaromeu@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Antonio Pellicer, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susana Martínez, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mónica Romeu, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José J. Martínez, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federico Moscardo, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniela Galliano, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María José Escribá, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susana Martínez, Doctor</last_name>
      <phone>961244000</phone>
      <phone_ext>244116</phone_ext>
      <email>susamc12@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Mónica Romeu, Doctor</last_name>
      <phone>961244000</phone>
      <phone_ext>244116</phone_ext>
      <email>monicaromeu@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Antonio Pellicer, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Munné S, Cohen J, Sable D. Preimplantation genetic diagnosis for advanced maternal age and other indications. Fertil Steril. 2002 Aug;78(2):234-6.</citation>
    <PMID>12137856</PMID>
  </reference>
  <reference>
    <citation>Garcia-Velasco JA, Isaza V, Requena A, Martínez-Salazar FJ, Landazábal A, Remohí J, Pellicer A, Simón C. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod. 2000 Nov;15(11):2292-6.</citation>
    <PMID>11056121</PMID>
  </reference>
  <reference>
    <citation>La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010 Mar-Apr;16(2):113-30. Epub 2009 Sep 30. Review.</citation>
    <PMID>19793843</PMID>
  </reference>
  <reference>
    <citation>Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004 Mar 11;428(6979):145-50. Erratum in: Nature. 2004 Aug 26;430(7003):1062.</citation>
    <PMID>15014492</PMID>
  </reference>
  <reference>
    <citation>Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, Adams GB, Niikura Y, Tschudy KS, Tilly JC, Cortes ML, Forkert R, Spitzer T, Iacomini J, Scadden DT, Tilly JL. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005 Jul 29;122(2):303-15.</citation>
    <PMID>16051153</PMID>
  </reference>
  <reference>
    <citation>Hong H, Yen HY, Brockmeyer A, Liu Y, Chodankar R, Pike MC, Stanczyk FZ, Maxson R, Dubeau L. Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Res. 2010 Jan 1;70(1):221-8. doi: 10.1158/0008-5472.CAN-09-3232. Epub 2009 Dec 22.</citation>
    <PMID>20028858</PMID>
  </reference>
  <reference>
    <citation>Eggan K, Jurga S, Gosden R, Min IM, Wagers AJ. Ovulated oocytes in adult mice derive from non-circulating germ cells. Nature. 2006 Jun 29;441(7097):1109-14. Epub 2006 Jun 14.</citation>
    <PMID>16799565</PMID>
  </reference>
  <reference>
    <citation>Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA. 2004 Jul 7;292(1):81-5.</citation>
    <PMID>15238594</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>October 19, 2013</lastchanged_date>
  <firstreceived_date>October 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario La Fe</investigator_affiliation>
    <investigator_full_name>Dr. Antonio Pellicer Martínez</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
